Bioequivalence Study of Moksi® 400mg Tablet and Avelox® 400mg Tablet (Moxifloxacin) Under Fasting Condition in Healthy Adult Pakistani Subjects
Clinical trial NCT05307614 · COMPLETED
Trial details
- NCT number
- NCT05307614
- Sponsor
- Abbott
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-27
- Primary completion
- 2019-04-23
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.